Acrivon Therapeutics (NASDAQ:ACRV) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Acrivon Therapeutics (ACRV) operate in?

Acrivon Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Acrivon Therapeutics Stock (NASDAQ: ACRV) stock price, news, charts, stock research, profile.

Open	$7.67
Close	$7.44
Volume / Avg.	77.58K / 87.17K
Day Range	$7.36 - $7.82
52 Wk Range	3.19 - 11.90
Market Cap	$231.65M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	50
Short Interest	9.29%
Days to Cover	20.92

Recent News

Athira Completes Dosing in Alzheimer's Study, Stock Up

Athira Pharma, Inc (NASDAQ: ATHA) recently announced that it has dosed the last patient in the phase II/III LIFT-AD study, which is evaluating its pipeline candidate, fosgonimeton for the treatment of mild-to-moderate Alzheimer's disease (AD).

Zacks

Beam Therapeutics Begins Dosing in Phase I/II AATD Study

Beam Therapeutics Inc. (NASDAQ: BEAM) announced that it has dosed the first patient in the phase I/II study, evaluating its investigational in vivo base editing therapy, BEAM-302, for the treatment of alpha-1 antitrypsin deficiency (AATD).

Zacks

Ultragenyx Posts New Data From Bone Disease Study

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), along with partner Mereo BioPharma (MREO), announced new positive 14-month data from the phase II portion of the phase II/III Orbit study evaluating setrusumab (UX143) in patients with osteogenesis imperfecta.

Zacks

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Aug

Sep

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$7.67
Close	$7.44
Volume / Avg.	77.58K / 87.17K
Day Range	$7.36 - $7.82
52 Wk Range	3.19 - 11.90
Market Cap	$231.65M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	50
Short Interest	9.29%
Days to Cover	20.92

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Acrivon Therapeutics (ACRV) stock?

You can purchase shares of Acrivon Therapeutics (NASDAQ:ACRV) through any online brokerage.

View our list of the best stock brokerages

Who are Acrivon Therapeutics (ACRV) competitors?

Other companies in Acrivon Therapeutics’s space includes: Macrogenics (NASDAQ:MGNX), Molecular Partners (NASDAQ:MOLN), Precigen (NASDAQ:PGEN), Zentalis Pharma (NASDAQ:ZNTL) and Tevogen Bio Holdings (NASDAQ:TVGN).

What is the forecast, or price target, for Acrivon Therapeutics (ACRV) stock?

Acrivon Therapeutics has a consensus price target of $22.67.

What is the current price for Acrivon Therapeutics (ACRV)?

The stock price for Acrivon Therapeutics (NASDAQ: ACRV) is $7.44 last updated December 2, 2024 at 4:02 PM EST.

Does Acrivon Therapeutics (ACRV) pay a dividend?

There are no upcoming dividends for Acrivon Therapeutics.

When is Acrivon Therapeutics (NASDAQ:ACRV) reporting earnings?

Acrivon Therapeutics’s Q3 earnings are confirmed for Wednesday, November 13, 2024.

Is Acrivon Therapeutics (ACRV) going to split?

There is no upcoming split for Acrivon Therapeutics.

What sector and industry does Acrivon Therapeutics (ACRV) operate in?

Acrivon Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Acrivon Therapeutics

Acrivon Therapeutics (ACRV) Forecast

Acrivon Therapeutics (NASDAQ:ACRV) Stock Quotes, Forecast and News Summary

Recent News

Financials

Analyst Trends and Forecast

Analyst Rating and Forecast

Compare

FAQ

How do I buy Acrivon Therapeutics (ACRV) stock?

Who are Acrivon Therapeutics (ACRV) competitors?

What is the forecast, or price target, for Acrivon Therapeutics (ACRV) stock?

What is the current price for Acrivon Therapeutics (ACRV)?

Does Acrivon Therapeutics (ACRV) pay a dividend?

When is Acrivon Therapeutics (NASDAQ:ACRV) reporting earnings?

Is Acrivon Therapeutics (ACRV) going to split?

What sector and industry does Acrivon Therapeutics (ACRV) operate in?

People Also Watch

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga